Suggest a news
Latest news
On World AIDS Day 2025, the International AIDS Society (IAS) and Geneva University Hospitals (HUG) announced that Geneva has been…
Valais-based Pacrim Group has taken a major strategic step in the Swiss life-science landscape by acquiring a controlling majority of Medropharm AG, a pioneer in pharmaceutical-grade cannabis. Announced on 21 October 2025, the transaction positions Pacrim — together with its subsidiary Alponics SA — as Switzerland’s only fully integrated medicinal cannabis enterprise, spanning the entire value chain from plant genetics to patient-ready products.
The Global Innovation Summit 2026 is taking place on 6 May 2026 in Basel and is the opportunity to kick…